Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4031 Target Snapshot

Beta-3 adrenergic receptor · SINGLE PROTEIN · Rattus norvegicus

234Compounds
37Assays
4Approved Drugs
53.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P26255. Use UniProt P26255 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P26255 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-3 adrenergic receptor as ChEMBL target CHEMBL4031, mapped to UniProt P26255. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-3 adrenergic receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4031
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P26255
Beta-3 adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-3 adrenergic receptor is the right protein anchor across sources, using UniProt P26255 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-3 adrenergic receptor
UniProt AccessionP26255
Component TypeProtein
Sequence Length400 aa

Beta-3 adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-3 adrenergic receptor, mapped to UniProt P26255. Sequence length is 400 aa.

Mapped IDP26255
Review nameBeta-3 adrenergic receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC501.0
KI3.0
EC5049.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL32670 9.03 EC50 0.9333 Preclinical
CHEMBL3128194 8.89 EC50 1.3 Preclinical
CHEMBL284782 8.66 EC50 2.188 Preclinical
CHEMBL32590 8.52 EC50 3.0 Preclinical
CHEMBL2012521 8.3 EC50 5.0 Preclinical
CHEMBL32586 8.25 EC50 5.623 Preclinical
CHEMBL421193 8.22 IC50 6.0 Preclinical
CHEMBL251372 8.19 EC50 6.5 Preclinical
CHEMBL221188 8.17 EC50 6.8 Preclinical
CHEMBL32933 8.14 EC50 7.244 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
2
5.5
8
6.0
4
6.5
5
7.0
13
7.5
7
8.0
3
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VIBEGRON
CHEMBL2107826
Approved 2018
RITODRINE
CHEMBL83063
Approved 1982
ISOPROTERENOL
CHEMBL434
Approved 1956
Assay Landscape

Assay Landscape

37
Total Assays
42
Tested Compounds
2
Assay Types
Functional — 26 assays, 42 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 11 13 6.7
assay format 6 24 7.5
tissue-based format 5 5 7.6
organism-based format 2 0
cell-free format 1 0
single protein format 1 0
Binding — 11 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
mitochondrion format 6 0
single protein format 4 1 6.3
tissue-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine